EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

PIK3CA mutation subtype delineates distinct immune profiles in gastric carcinoma

Sangjoon Choi, Hyunjin Kim, You Jeoung Heo, So Young Kang iD, Soomin Ahn, Jeeyun Lee, Kyoung-Mee Kim iD

The Journal of Pathology · 2023

DOI: 10.1002/path.6134 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Journal of Pathology, 2023. Verfasst von Sangjoon Choi und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology and Translational Genomics, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea. Hauptthemen laut MEDLINE: Epstein-Barr Virus Infections, Stomach Neoplasms, Carcinoma. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

PIK3CA mutations in cancer regulate tumour immunogenicity. Given that PIK3CA mutation subtypes influence therapeutic responses to AKT inhibitor and that H1047R mutation confers selective growth advantages after immunotherapy, we hypothesised that immune phenotypes may depend on PIK3CA mutation subtypes. We investigated 133 gastric cancers (GCs) harbouring PIK3CA mutation [21 E542K (15.8%), 36 E545X (27.1%), 26 H1047X (19.5%), and 46 others (34.6%)]. Four patients (3.0%) had a combination of mutations (E542K + E545K in 3 patients and E545K + H1047R in 1 patient). Epstein–Barr virus (EBV) and microsatellite instability (MSI) status, PD‐L1 (programmed death‐ligand 1) combined positive score (CPS), and stromal tumour‐infiltrating lymphocytes (TILs) were assessed. Concurrent genomic alterations, GeoMx digital spatial profiling (DSP), and OPAL multiplex immunohistochemistry (mIHC) were analysed, and correlation between the two assays was investigated. Of the 133 PIK3CA ‐mutant ( PIK3CA m ) GCs, MSI‐high GC was significantly frequent in the H1047X mutation subtype ( p = 0.005), while EBV positivity did not affect the mutation subtypes. There was no significant survival difference between the E542K, E545X, and H1047X subgroups. However, in the subgroup analysis for EBV‐positive GC, H1047X m GC showed a trend towards shorter survival than E542K and E545X m GC ( p = 0.090 and 0.062). With DSP analysis, H1047X m GC showed elevated VISTA ( p = 0.0003), granzyme B ( p < 0.0001), CD4 ( p = 0.0001), and CD45 ( p < 0.0001) expression compared with the E542K m or E545X m GC subgroups, and only VISTA expression remained significant ( p < 0.0001) using OPAL mIHC. DSP and OPAL analyses showed a moderate correlation of CD4 ( ρ = 0.42, p = 0.004) and CD8 ( ρ = 0.62, p < 0.001) expression levels in a comparison of six antibodies. Immune‐related protein expression levels were evident when classified by the three PIK3CA hotspot mutations, and H1047X m GC showed the highest immune‐related protein expression compared with E542K m or E545X m GC. Our results demonstrated distinct immune profiles in GC with PIK3CA hotspot mutations using GeoMx DSP and OPAL mIHC, and there was a correlation between the two multiplex platforms. © 2023 The Authors. The Journal of Pathology published by John Wiley & Sons Ltd on behalf of The Pathological Society of Great Britain and Ireland.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Epstein-Barr Virus InfectionsStomach NeoplasmsCarcinomaHumansHerpesvirus 4, HumanMicrosatellite InstabilityB7-H1 AntigenClass I Phosphatidylinositol 3-KinasesMutation

Stichwörter der Autor:innen

Epstein-Barr virusPIK3CA mutationgastric cancerimmune microenvironmentmicrosatellite instability

Substanzen

B7-H1 AntigenClass I Phosphatidylinositol 3-KinasesPIK3CA protein, human

Autor:innen und Institutionen

  • Department of Pathology and Translational Genomics, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea.
  • Pathology Center, Seegene Medical Foundation, Seoul, Republic of Korea.
  • The Samsung Advanced Institute for Health Sciences & Technology (SAIHST), Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea.
  • Center of Companion Diagnostics, Samsung Medical Center, Seoul, Republic of Korea.
  • Department of Medicine, Division of Hematology-Oncology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea.

ORCID-Profile: So Young Kang, Kyoung-Mee Kim

Zitieren

APA

Choi, S., Kim, H., Heo, Y. J., Kang, S. Y., Ahn, S., Lee, J., & Kim, K. M. (2023). PIK3CA mutation subtype delineates distinct immune profiles in gastric carcinoma. The Journal of Pathology. https://doi.org/10.1002/path.6134

Vancouver

Choi S, Kim H, Heo YJ, Kang SY, Ahn S, Lee J, et al. PIK3CA mutation subtype delineates distinct immune profiles in gastric carcinoma. The Journal of Pathology. 2023. doi:10.1002/path.6134

BibTeX
@article{Choi2023,
  author = {Choi, Sangjoon and Kim, Hyunjin and Heo, You Jeoung and Kang, So Young and Ahn, Soomin and Lee, Jeeyun and Kim, Kyoung-Mee},
  title = {PIK3CA mutation subtype delineates distinct immune profiles in gastric carcinoma},
  journal = {The Journal of Pathology},
  year = {2023},
  doi = {10.1002/path.6134}
}
Kostenlos starten →